Ravelcare Ltd IPO (Dec 2025): Beauty, Branding & Burn Rates — The ₹24 Cr Digital Vanity Parade You Didn’t See Coming

1. At a Glance

Ravelcare Ltd, the digital-first beauty and personal care brand, has decided to sprinkle some IPO glitter worth ₹24.10 crore into the Indian SME market. With its issue opening on December 1, 2025 and closing on December 3, 2025, the company aims to list on the BSE SME by December 8, 2025. The IPO price band is ₹123–₹130 per share — because apparently, even valuations need a touch of vanity.

At the upper price band, the company’s market cap is around ₹89.17 crore, which is roughly what Nykaa spends on influencer campaigns in a week. The minimum retail investment? ₹2.6 lakh for just two lots — because beauty ain’t cheap, even for investors.

With PAT of ₹5.26 crore and an EPS of ₹10.5 (pre-issue), Ravelcare trades at a P/E of ~12.4x, which isn’t bad — if you believe the beauty sector has margins thicker than your favourite concealer. But after the issue, the P/E inflates to ~13.95x, which is as stretched as a marketing intern’s content calendar before launch week.

Now here’s the punch: most of the issue proceeds (₹11.50 crore) go toward marketing and brand visibility. Translation: a massive influencer campaign is probably already filming somewhere in Bandra.

So — is this an exciting digital beauty unicorn in the making or just another Instagram filter with a valuation? Let’s dig in.

2. Introduction

Welcome to Ravelcare, where science meets selfies. Founded in 2018, this Mumbai-based beauty brand has a simple mission — to personalize your hair and skin routine while making your wallet feel the exfoliation.

Ravelcare is part of India’s booming BPC (Beauty and Personal Care) market — a segment growing faster than the number of “Get Ready With Me” videos on YouTube. With operations that began humbly through online platforms like Amazon, Flipkart, and Myntra, the company has since expanded into Blinkit, UAE, Canada, and the USA — because if your shampoo can’t ship internationally, are you even a D2C brand?

The IPO’s timing is no coincidence. The D2C wave is real — India’s young consumers want personalized everything, from skincare to investment advice (hi 👋). And Ravelcare’s strategy is to milk this personalization obsession with data-driven product lines.

But the real twist? Despite being “digital-first,” Ravelcare plans to invest ₹7.84 crore to build a manufacturing facility in Amravati. Nothing screams startup maturity like shifting from influencer tie-ups to industrial land acquisition.

So yes, they’ve got ambition. They’ve got growth. And most importantly, they’ve got marketing spend. But whether that converts into long-term shareholder glow-up is a story that’s just beginning.

3. Business Model – WTF Do They Even Do?

Ravelcare’s business model is textbook D2C (Direct-to-Consumer) with a twist of digital glam. It’s built on four pillars — Haircare, Skincare, Bodycare, and Scalpcare — each designed to make you believe your hair fall has a unique personality.

The magic lies in their personalized consultation system. Customers fill out forms online — telling Ravelcare their skin type, hair woes, and existential concerns — and in return, get “customized” product suggestions. Essentially, it’s like Tinder for skincare, but with less heartbreak and more serums.

Here’s the punchline:
They don’t actually manufacture most of it yet. As of now, Ravelcare uses contract manufacturing, but plans to shift production in-house via its Amravati facility. This move aims to reduce dependency and improve margins (and maybe even ensure the shampoos stop smelling suspiciously like competitors’).

The brand also relies heavily on online channels — Amazon, Flipkart, Myntra, and Blinkit — to push volumes. They’ve also started global shipping to the UAE, USA, Canada, Germany, and Saudi Arabia, which sounds fancy until you realize “international presence” in startup speak could mean one order a week from a cousin abroad.

Their digital-first DNA means lower retail costs and higher customer engagement. Every click, every review, and every abandoned cart is data. And in 2025, data is sexier than collagen peptides.

4. Financials Overview

Let’s see what’s brewing beneath that serum bottle: